Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.10.0.1
Warrants
6 Months Ended
Jun. 30, 2018
Text Block [Abstract]  
Warrants

5. Warrants

On April 6, 2018 (the “Closing Date”), the Company entered into a securities purchase agreement with certain new institutional investors for the purchase and sale of 900,000 shares of the Company’s common stock in a registered direct offering. The Company also issued unregistered warrants to the investors in a concurrent private placement to purchase up to an equivalent number of shares of the Company’s common stock with an exercise price of $2.00 per share. The warrants are exercisable six months following the Closing Date and will expire five years from the date of issuance. A summary of warrant activity for the year ended December 31, 2017 and the six months ended June 30, 2018 is as follows:

 

     Warrants      Weighted
Average
Price
 

Balance - December 31, 2016

     17,559      $ 1.50  

Granted

     2,177,425        3.10  

Exercised

     —          —    

Expired

     (17,559      1.50  
  

 

 

    

 

 

 

Balance - December 31, 2017

     2,177,425        3.10  

Granted

     900,000        2.00  

Exercised

     —          —    

Expired

     —          —    
  

 

 

    

 

 

 

Balance - June 30, 2018

     3,077,425      $ 2.78  
  

 

 

    

 

 

 

The warrants outstanding as of June 30, 2018 are as follows:

 

Exercise Price

   Warrants
Outstanding
     Expiration
Date
 
$          3.10      48,387        9/19/2022  
$          3.10      462,106        5/10/2024  
$          3.10      602,414        7/25/2024  
$          3.10      1,064,518        11/8/2024  
$          2.00      900,000        4/10/2023  
  

 

 

    
     3,077,425